Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
-53.6%  /
54.0%
35.7x
22.0x
7.1x
28.6%
-281.0%
..
2.4%
-39.6% 
-48.6%  /
34.9%
20.6x
8.6x
8.9x
96.3%
161.5%
..
10.6%
18.1% 
-63.6%  /
24.3%
>200x
42.9x
6.8x
-57.5%
570.0%
..
10.9%
83.8% 
13.6%  /
2.3%
7.7x
7.5x
7.7x
98.6%
688.9%
..
9.1%
89.2% 
-58.3%  /
77.2%
2.5x
2.5x
2.3x
117.9%
492.9%
..
14.4%
214.0% 
8.6%  /
3.0%
7.4x
6.2x
2.5x
44.4%
-16.7%
..
0.0%
-6.7% 
-96.5%  /
-20.6%
62.0x
26.0x
8.8x
37.1%
0.0%
..
16.0%
--- 
11.6%  /
-6.1%
>200x
0.0x
0.0x
21.1%
0.0%
..
7.6%
--- 
-83.0%  /
37.9%
25.6x
21.2x
9.3x
38.2%
-69.5%
..
2.8%
-7.5% 
-42.9%  /
24.3%
13.4x
4.9x
13.0x
117.6%
71.6%
..
5.3%
5.5% 
-89.5%  /
52.8%
12.1x
7.0x
8.9x
95.3%
12.5%
..
0.7%
1.4% 
-63.0%  /
15.3%
>200x
6.0x
5.0x
-42251.0%
-386.7%
..
13.8%
-77.5% 
>200%  /
27.8%
2.1x
2.6x
0.5x
24.1%
0.0%
..
8.1%
--- 
-78.2%  /
-12.1%
21.7x
20.0x
6.5x
28.4%
-24.2%
..
1.3%
-3.7% 
11.6%  /
8.5%
3.0x
3.5x
0.7x
24.6%
0.0%
..
8.0%
--- 
-22.7%  /
7.2%
6.3x
11.2x
11.7x
109.6%
-395.6%
..
8.5%
-33.8% 
>200%  /
82.6%
>200x
16.8x
4.2x
-10.9%
58.1%
..
1.6%
13.7% 
-33.6%  /
49.0%
11.1x
7.2x
2.9x
37.7%
-110.8%
..
3.4%
-37.9% 
>200%  /
13.9%
>200x
11.4x
1.5x
17.7%
883.2%
..
3.5%
570.0% 
8.9%  /
2.3%
>200x
10.4x
0.8x
-2.5%
0.0%
..
3.1%
--- 
4.7%  /
-5.8%
>200x
10.9x
3.0x
27.8%
713.3%
..
2.9%
235.6% 
0.0%  /
0.0%
95.1x
42.2x
4.9x
11.3%
-273.2%
..
13.9%
-56.3% 
0.0%  /
0.0%
36.6x
>200x
10.3x
28.3%
0.0%
..
7.9%
--- 
7.1%  /
0.3%
5.6x
15.2x
2.6x
29.2%
88.4%
..
3.5%
33.8% 
-76.1%  /
-7.4%
16.5x
6.2x
6.7x
108.9%
-166.3%
..
12.1%
-25.0% 
0.0%  /
0.0%
0.4x
>200x
0.1x
17.5%
0.0%
..
0.0%
--- 
-75.0%  /
5.2%
33.9x
16.5x
7.4x
43.8%
-273.4%
2024-05-08
14.6%
-37.1% 
-7.7%  /
65.3%
>200x
3.1x
6.4x
-11263.3%
1150.0%
2024-05-08
13.9%
179.7% 
-3.6%  /
19.3%
>200x
3.9x
2.7x
-17.9%
0.0%
2024-05-08
7.4%
--- 
-22.2%  /
-7.8%
3.9x
8.3x
1.6x
27.3%
15.2%
2024-05-08
7.4%
9.4% 
-38.9%  /
57.4%
3.8x
3.3x
2.7x
103.9%
155.1%
2024-05-08
11.0%
57.4% 
-6.7%  /
42.2%
24.2x
11.9x
9.7x
80.4%
347.8%
2024-05-08
9.9%
36.0% 
-97.2%  /
53.7%
>200x
1.5x
2.6x
377.3%
19097.7%
2024-05-08
0.0%
7 371.1% 
0.0%  /
0.0%
3.3x
>200x
0.7x
21.8%
0.0%
2024-05-08
3.7%
--- 
-10.0%  /
61.4%
31.9x
30.5x
6.8x
18.4%
-5.1%
2024-05-08
2.4%
-0.7% 
-18.6%  /
7.7%
7.5x
9.5x
3.2x
37.0%
40.9%
2024-05-08
3.9%
12.9% 
12.9%  /
43.9%
2.1x
12.5x
0.0x
1.6%
0.0%
2024-05-08
0.0%
--- 
-72.7%  /
0.0%
4.4x
2.9x
6.7x
245.2%
445.2%
2024-05-08
10.5%
66.5% 
15.8%  /
25.3%
>200x
69.2x
3.8x
-1.6%
0.0%
2024-05-08
1.6%
--- 
-42.9%  /
79.3%
2.1x
5.5x
1.8x
18.2%
13.6%
2024-05-09
3.5%
7.7% 
7.5%  /
2.3%
15.3x
10.0x
3.9x
26.3%
0.0%
2024-05-09
2.6%
--- 
-64.4%  /
38.5%
22.9x
13.0x
10.0x
65.3%
-70.6%
2024-05-09
7.5%
-7.0% 
-100.0%  /
0.0%
2.5x
2.5x
4.1x
166.7%
0.0%
2024-05-13
9.6%
--- 
-75.0%  /
35.5%
16.3x
11.9x
11.8x
100.0%
45.5%
2024-05-13
12.4%
3.9% 
21.6%  /
6.5%
8.4x
7.4x
2.1x
25.9%
0.0%
2024-05-13
2.5%
--- 
100.0%  /
41.7%
>200x
0.8x
0.6x
-166.7%
0.0%
2024-05-13
0.0%
--- 
-60.0%  /
27.2%
20.2x
11.2x
10.4x
90.1%
-722.5%
2024-05-14
9.2%
-69.8% 
0.0%  /
44.9%
55.7x
20.1x
6.0x
37.8%
0.0%
2024-05-15
0.0%
--- 
1.3%  /
16.2%
3.2x
5.2x
0.2x
5.3%
0.0%
2024-05-15
3.5%
--- 
38.0%  /
26.4%
34.6x
31.3x
11.8x
35.2%
77.0%
2024-05-23
1.6%
6.5% 
11.4%  /
3.7%
19.3x
22.0x
6.5x
33.4%
0.0%
2024-07-14
2.5%
--- 
-2.4%  /
5.7%
25.9x
27.2x
7.2x
27.7%
0.0%
2024-07-20
3.3%
--- 
4.0%  /
-1.6%
>200x
9.0x
1.2x
-2.1%
0.0%
2024-07-25
7.1%
--- 
9.2%  /
5.1%
19.1x
20.1x
4.7x
18.9%
0.0%
2024-07-27
1.3%
--- 
11.7%  /
8.2%
11.4x
12.8x
1.4x
12.7%
0.0%
2024-07-28
5.1%
--- 
13.8%  /
2.3%
13.0x
15.6x
3.7x
29.1%
0.0%
2024-07-28
4.4%
--- 
12.1%  /
7.9%
11.8x
13.7x
2.0x
16.6%
0.0%
2024-07-28
3.2%
--- 
3.4%  /
4.0%
10.2x
11.2x
1.2x
11.8%
0.0%
2024-07-28
5.0%
--- 
12.8%  /
3.4%
12.1x
11.7x
2.7x
23.1%
0.0%
2024-08-02
6.4%
--- 
11.3%  /
-1.2%
11.2x
13.4x
2.4x
21.8%
0.0%
2024-08-02
4.7%
--- 
7.3%  /
18.7%
17.5x
23.2x
3.5x
19.9%
0.0%
2024-08-03
0.0%
--- 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2024-05-13
#reports #XPER

[Xperi](https://eninvs.com/all.php?name=XPER) (Semiconductor Equipment and Materials) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=168842)
(2024-05-08, After Market Close):

- Revenue -6.3% YoY (vs +0.7% in previous quarter and historical rate -11.8%)
- EBITDA margin -24.4% decreased compared to -23.6% same period last year
- Net Debt increased by $43.0 mln over the past reporting period (10.2% of market cap)
- FCF (LTM) +$0.0 bln (positive), 9.5% of market cap
- EV/Sales multiple is 0.7x

The company showed EPS +$0.01 per share. At the opening of the session the share price went down -5.2% vs S&P500 0.0%
2024-05-13
#reports #VZIO

[VIZIO Holding Corp.](https://eninvs.com/all.php?name=VZIO) (Consumer Electronics) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=VZIO&q=2024 q1&id=780535)
(2024-05-08, After Market Close):

- Revenue -0.8% YoY (vs -5.8% in previous quarter and historical rate -9.1%)
- EBITDA margin -5.4% decreased compared to -0.6% same period last year
- Net Debt increased by $18.0 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.0 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 169.8x compared to historical level (75th percentile) of 65.8x
- EV/Sales multiple is 1.0x

The company showed EPS -$0.06 per share. At the opening of the session the share price went down -1.5% vs S&P500 0.0%
2024-05-13
#reports #USPH

[U.S. Physical Therapy](https://eninvs.com/all.php?name=USPH) (Medical services provider) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=169238)
(2024-05-07, After Market Close):

- Revenue +4.7% YoY (vs +9.9% in previous quarter and historical rate +14.2%)
- EBITDA -14.3% YoY (vs -72.7% in previous quarter and historical rate -3.2%)
- EBITDA margin 11.5% decreased compared to 14.1% same period last year
- Net Debt decreased by $1.8 bln over the past reporting period (127.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 9.8% of market cap
- EV/EBITDA multiple is 48.4x compared to historical level (75th percentile) of 45.3x
- EV/Sales multiple is 5.1x

The company showed EPS +$0.46 per share. At the opening of the session the share price went down -2.8% vs S&P500 -0.4%
2024-05-13
#reports #SUPN

[Supernus Pharmaceuticals](https://eninvs.com/all.php?name=SUPN) (Pharmaceutical manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=SUPN&q=2024 q1&id=780506)
(2024-05-08, After Market Close):

- Revenue -6.5% YoY (vs -1.8% in previous quarter and historical rate +3.2%)
- EBITDA -19.5% YoY (vs -57.1% in previous quarter and historical rate -9.6%)
- EBITDA margin 22.9% decreased compared to 26.6% same period last year
- Net Debt decreased by $43.0 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) +$0.5 bln (positive), 32.4% of market cap
- EV/EBITDA multiple is 19.1x compared to historical level (75th percentile) of 19.4x
- EV/Sales multiple is 2.2x

The company showed EPS +$0.00 per share. At the opening of the session the share price went up +0.7% vs S&P500 0.0%
2024-05-13
#reports #STE

[STERIS](https://eninvs.com/all.php?name=STE) (Medical equipment supplier) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=STE&q=2024 q1&id=780502)
(2024-05-08, After Market Close):

- Revenue +2.5% YoY (vs +14.8% in previous quarter and historical rate +22.2%)
- EBITDA -5.6% YoY (vs +61.5% in previous quarter and historical rate +34.2%)
- EBITDA margin 30.7% decreased compared to 33.3% same period last year
- Net Debt increased by $1.0 mln over the past reporting period (0.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.6% of market cap
- EV/EBITDA multiple is 15.7x compared to historical level (75th percentile) of 28.8x
- EV/Sales multiple is 4.2x

The company showed EPS +$1.54 per share. At the opening of the session the share price went up +6.1% vs S&P500 0.0%
2024-05-13
#reports #SONX

[Sonendo, Inc.](https://eninvs.com/all.php?name=SONX) (Medical Devices) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=169041)
(2024-05-08, After Market Close):

- Revenue -36.4% YoY (vs -83.3% in previous quarter and historical rate -14.6%)
- EBITDA margin -142.9% decreased compared to -127.3% same period last year
- Net Debt decreased by $2.0 mln over the past reporting period (23.5% of market cap)
- FCF (LTM) -$0.0 bln (negative), 294.0% of market cap
- EV/Sales multiple is -0.0x

The company showed EPS -$0.07 per share. At the opening of the session the share price went up +7.3% vs S&P500 0.0%
2024-05-13
#reports #SNEX

[StoneX Group](https://eninvs.com/all.php?name=SNEX) (Financial service provider) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=168957)
(2024-05-08, After Market Close):

- Revenue +36.8% YoY (vs +50.4% in previous quarter and historical rate +75.5%)
- Net Income +26.2% YoY (vs -10.4% in previous quarter and historical rate +37.4%)
- Net Income margin 0.2% has not changed compared to 0.3% same period last year
- P/E multiple is 9.5x compared to historical level (75th percentile) of 8.7x
- P/S multiple is 0.0x
- Price to book: 1.5x

The company showed EPS +$1.63 per share. At the opening of the session the share price went up +0.1% vs S&P500 0.0%
2024-05-13
#reports #SMSI

[Smith Micro Software](https://eninvs.com/all.php?name=SMSI) (Software — Application) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=SMSI&q=2024 q1&id=780494)
(2024-05-08, After Market Close):

- Revenue -45.5% YoY (vs -18.2% in previous quarter and historical rate -7.6%)
- EBITDA margin -500.0% decreased compared to -45.5% same period last year
- Net Debt increased by $1.0 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.0 bln (positive), 3.2% of market cap
- EV/Sales multiple is 5.2x

The company showed EPS -$3.28 per share
2024-05-13
#reports #SBRA

[Sabra Health Care](https://eninvs.com/all.php?name=SBRA) (Real estate investment fund) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=169056)
(2024-05-08, After Market Close):

- Revenue +3.7% YoY (vs -1.2% in previous quarter and historical rate +3.2%)
- EBITDA +3.7% YoY (vs -1.2% in previous quarter and historical rate +41.9%)
- EBITDA margin 100.0% has not changed compared to 100.0% same period last year
- EV/EBITDA multiple is 8.8x compared to historical level (75th percentile) of 19.7x
- EV/Sales multiple is 8.7x

The company showed EPS +$0.11 per share. At the opening of the session the share price went down -0.8% vs S&P500 0.0%
2024-05-13
#reports #RGNX

[REGENXBIO](https://eninvs.com/all.php?name=RGNX) (Developer of viral gene therapy) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=169091)
(2024-05-08, After Market Close):

- Revenue -15.8% YoY (vs -29.0% in previous quarter and historical rate +2.6%)
- EBITDA margin -375.0% decreased compared to -331.6% same period last year
- Net Debt decreased by $65.0 mln over the past reporting period (9.6% of market cap)
- FCF (LTM) +$0.0 bln (positive), 1.8% of market cap
- EV/Sales multiple is 4.9x

The company showed EPS -$1.38 per share. At the opening of the session the share price went down -0.7% vs S&P500 0.0%
2024-05-13
#reports #RCUS

[Arcus Biosciences](https://eninvs.com/all.php?name=RCUS) (Medicines developer) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=RCUS&q=2024 q1&id=780470)
(2024-05-08, After Market Close):

- Revenue +480.0% YoY (vs -8.8% in previous quarter and historical rate +79.6%)
- EBITDA margin -9.7% increased compared to -336.0% same period last year
- Net Debt increased by $866.0 mln over the past reporting period (94.6% of market cap)
- FCF (LTM) -$0.2 bln (negative), 19.4% of market cap
- EV/Sales multiple is 0.2x

The company showed EPS -$0.05 per share. At the opening of the session the share price went up +11.1% vs S&P500 0.0%
2024-05-13
#reports #QRTEB

[Qurate Retail](https://eninvs.com/all.php?name=QRTEB) (Internet Retail) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=169026)
(2024-05-08, Before Market Open):

- Revenue -11.4% YoY (vs +140.5% in previous quarter and historical rate -1.9%)
- EBITDA -11.6% YoY (vs -100.7% in previous quarter and historical rate -4.0%)
- EBITDA margin 10.4% has not changed compared to 10.4% same period last year
- Net Debt increased by $166.0 mln over the past reporting period (28.3% of market cap)
- FCF (LTM) +$0.4 bln (positive), 71.5% of market cap
- EV/EBITDA multiple is 7.2x compared to historical level (75th percentile) of 6.2x
- EV/Sales multiple is 0.7x

The company showed EPS -$0.00 per share. At the opening of the session the share price went up +11.2% vs S&P500 -0.4%
2024-05-13
#reports #PYCR

[Paycor HCM, Inc.](https://eninvs.com/all.php?name=PYCR) (Software — Application) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=168862)
(2024-05-08, After Market Close):

- Revenue +16.1% YoY (vs +20.3% in previous quarter and historical rate +25.0%)
- EBITDA +150.0% YoY (vs -1000.0% in previous quarter)
- EBITDA margin 5.3% increased compared to 2.5% same period last year
- Net Debt decreased by $29.0 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.7% of market cap
- EV/Sales multiple is 3.9x

The company showed EPS +$0.03 per share. At the opening of the session the share price went down -4.9% vs S&P500 0.0%
2024-05-13
#reports #PSNL

[Personalis](https://eninvs.com/all.php?name=PSNL) (Diagnostics and Research) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=169066)
(2024-05-08, After Market Close):

- Revenue +5.3% YoY (vs +17.6% in previous quarter and historical rate -0.2%)
- EBITDA margin -85.0% increased compared to -147.4% same period last year
- Net Debt increased by $13.0 mln over the past reporting period (16.7% of market cap)
- FCF (LTM) -$0.0 bln (negative), 55.2% of market cap
- EV/Sales multiple is 0.3x

The company showed EPS -$0.26 per share. At the opening of the session the share price went up +9.3% vs S&P500 0.0%
2024-05-13
#reports #NPCE

[NeuroPace, Inc.](https://eninvs.com/all.php?name=NPCE) (Medical Devices) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=169067)
(2024-05-08, After Market Close):

- Revenue +28.6% YoY (vs +38.5% in previous quarter and historical rate +21.5%)
- EBITDA margin -38.9% increased compared to -57.1% same period last year
- Net Debt increased by $8.0 mln over the past reporting period (3.8% of market cap)
- FCF (LTM) -$0.0 bln (negative), 1.4% of market cap
- EV/Sales multiple is 3.2x

The company showed EPS -$0.32 per share. At the opening of the session the share price went down -1.4% vs S&P500 0.0%
2024-05-13
#reports #NL

[NL Industries](https://eninvs.com/all.php?name=NL) (Security and Protection Services) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=169206)
(2024-05-08, After Market Close):

- Revenue -7.3% YoY (vs +7.5% in previous quarter and historical rate +11.8%)
- EBITDA -68.2% YoY (vs +10.5% in previous quarter and historical rate +35.3%)
- EBITDA margin 18.4% decreased compared to 53.7% same period last year
- Net Debt increased by $142.0 mln over the past reporting period (36.9% of market cap)
- FCF (LTM) +$0.0 bln (positive), 2.3% of market cap
- EV/EBITDA multiple is 4.0x compared to historical level (75th percentile) of 3.8x
- EV/Sales multiple is 1.5x

The company showed EPS +$0.14 per share. At the opening of the session the share price went down -0.3% vs S&P500 0.0%
2024-05-13
#reports #MSEX

[Middlesex Water](https://eninvs.com/all.php?name=MSEX) (Water supply company) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=169197)
(2024-05-08, After Market Close):

- Revenue +7.9% YoY (vs 0.0% in previous quarter and historical rate +6.1%)
- EBITDA +23.1% YoY (vs -11.8% in previous quarter and historical rate +8.3%)
- EBITDA margin 39.0% increased compared to 34.2% same period last year
- Net Debt increased by $377.0 mln over the past reporting period (36.7% of market cap)
- EV/EBITDA multiple is 20.7x compared to historical level (75th percentile) of 30.1x
- EV/Sales multiple is 8.3x

The company showed EPS +$0.60 per share. At the opening of the session the share price went up +3.6% vs S&P500 0.0%
2024-05-13
#reports #MRVI

[Maravai LifeSciences Holdings, Inc.](https://eninvs.com/all.php?name=MRVI) (Biotechnology) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=MRVI&q=2024 q1&id=780423)
(2024-05-08, After Market Close):

- Revenue -19.0% YoY (vs -63.9% in previous quarter and historical rate +3.5%)
- EBITDA margin -139.1% decreased compared to -86.1% same period last year
- EV/Sales multiple is 5.0x

The company showed EPS -$0.09 per share. At the opening of the session the share price went up +3.2% vs S&P500 0.0%
2024-05-13
#reports #MRUS

[Merus](https://eninvs.com/all.php?name=MRUS) (Biotechnology) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=169112)
(2024-05-08, After Market Close):

- Revenue -38.5% YoY (vs -18.2% in previous quarter and historical rate +15.8%)
- EBITDA margin -575.0% decreased compared to -276.9% same period last year
- Net Debt increased by $17.0 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.0% of market cap
- EV/Sales multiple is 54.3x

The company showed EPS -$0.59 per share. At the opening of the session the share price went up +0.1% vs S&P500 0.0%
2024-05-13
#reports #MRC

[MRC Global](https://eninvs.com/all.php?name=MRC) (Pipelines and components manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=168725)
(2024-05-08, After Market Close):

- Revenue -8.9% YoY (vs -11.6% in previous quarter and historical rate +12.8%)
- EBITDA -28.4% YoY (vs -15.6% in previous quarter and historical rate +74.4%)
- EBITDA margin 6.0% decreased compared to 7.6% same period last year
- Net Debt decreased by $30.0 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0.2 bln (positive), 18.8% of market cap
- EV/EBITDA multiple is 9.0x compared to historical level (75th percentile) of 17.3x
- EV/Sales multiple is 0.6x

The company showed EPS +$0.22 per share. At the opening of the session the share price went up +4.9% vs S&P500 0.0%
2024-05-13
#reports #MNKD

[MannKind Corporation](https://eninvs.com/all.php?name=MNKD) (Biotechnology) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=169246)
(2024-05-08, After Market Close):

- Revenue +61.0% YoY (vs +61.1% in previous quarter and historical rate +65.6%)
- EBITDA margin 27.3% increased compared to -9.8% same period last year
- Net Debt decreased by $11.0 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 13.4% of market cap
- EV/EBITDA multiple is 29.7x compared to historical level (75th percentile) of 80.1x
- EV/Sales multiple is 4.7x

The company showed EPS +$0.03 per share. At the opening of the session the share price went up +3.4% vs S&P500 0.0%